Loading company details...
Beta
Latest Form 4 (Aug 20, 2026): Adeoye Y. Olukotun (Director): Sale of 2,000 shares, $173.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Adeoye Y. Olukotun | Sale | 2,000 | $173.9K |
| Aug 20, 2026 | Michael S. Perry | Sale | 11,600 | $1.01M |
| Jun 18, 2026 | Matthew Gregory Cohen | Grant/Award | 11,882 | n/a |
| May 14, 2026 | Hongbo Lu | Sale | 2,970 | $228.3K |
| Apr 24, 2026 | Daniel Joseph Apel, Chief Financial Officer | Sale | 3,208 | $224.9K |
| Apr 24, 2026 | James C. Hamilton, Chief Medical Officer | Sale | 10,000 | $750.0K |
| Mar 9, 2026 | James C. Hamilton, Chief Medical Officer | Sale | 10,000 | $641.9K |
| Jan 8, 2026 | James C. Hamilton, Chief Medical Officer | Grant/Award | 75,000 | n/a |
| Jan 8, 2026 | Daniel Joseph Apel, Chief Financial Officer | Grant/Award | 75,000 | n/a |
| Jan 8, 2026 | Patrick O'Brien, COO | Gift | 540 | n/a |